TY - JOUR AU - Laszlo, G. S. PY - 2015 DA - 2015// TI - High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children’s Oncology Group JO - J Hematol Oncol VL - 8 UR - https://doi.org/10.1186/s13045-015-0215-4 DO - 10.1186/s13045-015-0215-4 ID - Laszlo2015 ER -